Tenet Healthcare Holds Annual Shareholder Meeting

Tenet Healthcare ( (THC) ) has shared an announcement.

On May 22, 2025, Tenet Healthcare Corporation held its Annual Meeting of Shareholders, where several key decisions were made. Shareholders elected directors to the board, approved executive compensation, and ratified Deloitte & Touche LLP as the independent accountants for 2025. However, a proposal for a report on improving maternal health outcomes was not approved, indicating a lack of consensus on this issue among shareholders.

The most recent analyst rating on (THC) stock is a Buy with a $184.00 price target. To see the full list of analyst forecasts on Tenet Healthcare stock, see the THC Stock Forecast page.

Spark’s Take on THC Stock

According to Spark, TipRanks’ AI Analyst, THC is a Outperform.

Tenet Healthcare demonstrates strong financial performance and technical momentum, with an attractive valuation. Key strengths include robust EBITDA growth and strategic capital management. However, the company must address revenue growth challenges and policy uncertainties to sustain this performance.

To see Spark’s full report on THC stock, click here.

More about Tenet Healthcare

Tenet Healthcare Corporation operates in the healthcare industry, providing a range of healthcare services primarily through its network of hospitals and outpatient centers. The company focuses on delivering high-quality care and improving health outcomes for patients across various communities.

Average Trading Volume: 1,642,636

Technical Sentiment Signal: Buy

Current Market Cap: $15.14B

Find detailed analytics on THC stock on TipRanks’ Stock Analysis page.